Trial Profile
Clinical Trials Insight: 700013082
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 May 2006
Price :
$35
*
At a glance
- Drugs Bavituximab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 23 May 2006 New trial record.